Related Experiment Video
Updated: Jul 5, 2025

Thermostabilization, Expression, Purification, and Crystallization of the Human Serotonin Transporter Bound to S-citalopram
Published on: November 27, 2016
Membrane Transporter of Serotonin and Hypercholesterolemia in Children
Dinara Sadykova1, Razina Nigmatullina2, Karina Salakhova1
1Department of Hospital Pediatrics, Kazan State Medical University, 420012 Kazan, Russia.
Insights
Children with familial hypercholesterolemia show higher serotonin levels and transporter concentrations, linked to arterial stiffness and vascular remodeling. This highlights serotonin
Area of Science:
- Cardiovascular Medicine
- Genetics
- Biochemistry
Background:
- Serotonin membrane transporter regulates plasma serotonin, impacting cardiovascular disease via smooth muscle cell proliferation and vascular remodeling.
- Vascular remodeling is a key factor in atherosclerosis, the primary manifestation of familial hypercholesterolemia (FH).
- Familial hypercholesterolemia is a common genetic lipid disorder affecting 1 in 313 individuals.
Purpose of the Study:
- To investigate plasma and platelet serotonin, 5-hydroxyindoleacetic acid, and serotonin transporter levels in children with FH versus healthy controls.
- To explore the relationship between these biomarkers and arterial vascular stiffness indicators in pediatric populations.
Main Methods:
- Cross-sectional study involving 116 children (ages 5-17), comprising a group with familial hypercholesterolemia and a control group of healthy children.
- Measurement of plasma and platelet serotonin, 5-hydroxyindoleacetic acid, and serotonin transporter concentrations.
- Assessment of arterial vascular stiffness using indicators like pulse wave velocity (PWV).
Main Results:
- Children with familial hypercholesterolemia exhibited significantly higher concentrations of plasma and platelet serotonin and 5-hydroxyindoleacetic acid compared to controls.
- Platelet serotonin transporter concentration was 1.3 times higher in healthy children than in the FH group.
- Positive correlations were found between serotonin levels (5-HT), serotonin transporter (SERT), and arterial stiffness indicators (PWV).
Conclusions:
- Elevated serotonin and serotonin transporter concentrations are associated with increased arterial stiffness in children with familial hypercholesterolemia.
- These findings suggest a potential role for serotonin and its transporter in the vascular remodeling processes associated with pediatric FH.
- Further research is warranted to elucidate the precise mechanisms and therapeutic implications of serotonin pathway involvement in pediatric cardiovascular health.
Abstract:
The serotonin membrane transporter is one of the main mechanisms of plasma serotonin concentration regulation. Serotonin plays an important role in the pathogenesis of various cardiovascular diseases, stimulating the proliferation of smooth muscle cells, key cells in the process of hypertrophic vascular remodeling. Vascular remodeling is one of the leading prognostically unfavorable factors of atherosclerosis, the main manifestation of familial hypercholesterolemia. Familial hypercholesterolemia is one of the most common genetically determined lipid metabolism disorders and occurs in 1 in 313 people. The aim of our study was to investigate the levels of plasma and platelet serotonin, 5-hydroxyindoleacetic acid, and membrane transporter in a cross-sectional study of two pediatric groups, including patients with familial hypercholesterolemia and the control group, which consisted of apparently healthy children without cardiovascular diseases. The study involved 116 children aged 5 to 17 years old. The proportion of boys was 50% (58/116) and the average age of the children was 10.5 years (CI 2.8-18.1). The concentrations of serotonin in blood plasma and platelets and 5-hydroxyindoleacetic acid were higher in children with familial hypercholesterolemia than in the controls. The concentration of the serotonin transporter in platelets in healthy children, compared with the main group, was 1.3 times higher. A positive correlation was revealed between the level of serotonin (5-HT and PWV: ρ = 0.6, p < 0.001), its transporter (SERT and PWV: ρ = 0.5, p < 0.001), and the main indicators of arterial vascular stiffness. Our study revealed the relationship between high serotonin and SERT concentrations and markers of arterial stiffness. The results we obtained suggest the involvement of serotonin and SERT in the process of vascular remodeling in familial hypercholesterolemia in children.
Related Concept Videos
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Membrane Transporters
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Hepatic Drug Clearance: Role of Transporters

